Table 4.
Final body weights, daily food intake, and flank organ area in testosterone- and DHT-treated SPS groups1.
| Treatment of right flank organ with testosterone or DHT + ethanol or SPS | Final body weights (g) | Daily food intake (g) | Flank organ area (mm2) | |
|---|---|---|---|---|
| Left (untreated) | Right (treated) | |||
| Testosterone + ethanol (control) | 104.0 ± 2.4 | 8.7 ± 0.3 | 19.8 ± 0.7 | 22.7 ± 2.9 |
| Testosterone + HLLP SPS | 110.7 ± 3.5 | 8.1 ± 0.2 | 19.2 ± 1.6 | 18.9 ± 1.3 |
| Testosterone + HLHP SPS | 106.4 ± 4.4 | 8.1 ± 0.2 | 18.0 ± 0.9 | 20.2 ± 1.3 |
| Testosterone + HMLP SPS | 109.9 ± 4.8 | 8.3 ± 0.2 | 17.6 ± 1.4 | 19.1 ± 1.2 |
| DHT + ethanol (control) | 103.6 ± 2.5 | 7.9 ± 0.2 | 22.4 ± 1.2 | 23.5 ± 1.6 |
| DHT + HLLP SPS | 103.9 ± 4.3 | 8.1 ± 0.3 | 19.0 ± 2.2 | 22.3 ± 2.4 |
| DHT + HLHP SPS | 100.9 ± 5.8 | 8.4 ± 0.3 | 18.0 ± 1.4 | 19.1 ± 1.5 |
| DHT + HMLP SPS | 108.4 ± 5.2 | 7.9 ± 0.2 | 20.4 ± 1.1 | 21.9 ± 1.9 |
10.5 µg testosterone or DHT was dissolved in 5 µL ethanol. Data are expressed as mean ± SEM (p < 0.05).